Relationship Between Plasma Homocysteine and Vitamin B12 Levels in Clinically Diagnosed Cases of Cardiovascular Accident in Lagos, Nigeria by Osunkalu, O et al.
 
Sierra Leone Journal of Biomedical Research          ISSN 2076-6270 




Relationship Between Plasma Homocysteine and Vitamin B12 Levels in 
Clinically Diagnosed Cases of Cardiovascular Accident in Lagos, Nigeria 
 
Osunkalu Vincent O1*, Akanmu Alani S1, Awodele Olufunsho2, Ayoola Gloria A3, 
Adediran Adewumi1, Agada Nonye3, Akinde Olakanmi R4 
 
1
Department of Haematology and Blood Transfusion, 
2









Vitamin B12 deficiency interferes with the normal pathway for homocysteine metabolism, even in the 
presence of adequate serum folate and pyridoxine. Homocysteinaemia, is an elevated level of homocysteine 
in plasma which has been established as a risk factor for the development of cardiovascular disorders. 
However, there has been conflicting report from various research works on the role of Vitamin B12 in the 
occurrence of major cardiovascular disorders. The study was set to determine the mean values of 
homocysteine, and correlate same with mean plasma levels of vitamin B12 in the subjects, and to estimate 
the prevalence of anaemia in the stroke patients, using Haemoglobin concentration (Hb) and mean 
corpuscular volume (MCV) as indices. One hundred (100) participants were recruited, comprising 40 
clinically diagnosed stroke patients (hemorrhagic or thrombo-embolic), and 60 normal adults as control 
group. Plasma homocysteine levels were measured by HPLC and plasma vitamin B12 levels by 
Chemiluminescent Microparticle Immuno-assay method.  Anticoagulated whole blood samples were 
evaluated for Hb, and MCV using automated Advia-60. Mean value of plasma homocysteine for the stroke 
patients (17.7±4.4umol/l) was significantly higher than values obtained in the control group at 9.5±2.4umol/l 
(p<0.001). Mean plasma vitamin B12 levels for both the stroke patients and controls were 249±14.5 pmol/l 
and 203.6±20.5 pmol/l respectively (p=0.029). The MCV for the study group (85fl) were significantly higher 
than those of the control group (82fl), p=0.040. However, the study showed no correlation between rising 
plasma homocysteine in stroke patient and vitamin B12 deficiency. 
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INTRODUCTION  
Stroke is the second commonest cause of death 
and the principal cause of adult disability in 
Nigeria (Nwosu et al., 1992). The current 
prevalence of stroke in Nigeria is 1·14 per 1000 
while the 30-day case fatality rate is as high as 
40% (Nwosu et al., 1992). Management of the 
disease is largely conservative therefore primary 
prevention is the key to reducing the increasing 
burden of stroke in Nigeria. Besides, socio-
demographic factors, other biochemical factors 
such as: rising plasma homocysteine, folate 
deficiency, vitamin B12 deficiency, including 
genetic disorders of folate metabolism (677CT 
polymorphism in MTHFR gene) are being 
implicated in the possible aetio-pathogenesis of 
cerebrovascular accident (Rajkovic et al., 2004).  
 
Normal fasting plasma homocysteine level ranges 
between 5-15 μmol/l (Boushey et al., 1995).  
Intracellular homocysteine either enters the trans-
sulfuration pathway or the remethylation cycle 
(Hoffbrand et al., 2001).  
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Approximately 50% of homocysteine enters the 
trans-sulfuration pathway, where it is irreversibly 
combined with serine by the vitamin B6-
dependent enzyme cysthathionine beta-synthase 
to form cysthathionine (Rosenblatt et al., 1999) 
This is then metabolized to cysteine and 
ultimately to sulphate which is excreted in the 
urine (Tan, 2000). The methylation of Vitamin B12 
to methyl B12 by tetrahydrofolate and subsequent 
methylation of homocysteine to methionine 
ensures a low plasma level of harmful 
homocysteine (Rosenblatt et al., 1999). 
Impairment of these mechanisms resulting from 
deficiencies of folate, vitamin B12, or other 
enzymes involved in these pathways, ultimately 
lead to rising plasma homocysteine levels with 
subsequent vascular endothelial damage (Allen et 
al., 1993). Clinical manifestation in these patients 
may include: mental retardation (Barbe et al, 
2009), skeletal abnormalities (Haddad et al., 
1999), lens dislocation (Nwosu et al.,1992), early 
arterosclerosis (Lentz et al., 1996) and various 
thrombo-embolic phenomenon of which stroke is 
of major public health concern in our environment.  
 
The effect of folate lack as possible risk factor for 
hyperhomocysteinaemia and ultimately 
cardiovascular disorders have been extensively 
documented. Therefore, this study seeks to 
establish possible relationship between plasma 
homocysteine and vitamin B12 in clinically 
diagnosed stroke patients in Nigeria, as limited 
local data exists on this subject among the 
population. 
 
MATERIALS AND METHODS  
Study Centre, Population and Design 
The study was carried out between March and 
April 2007, at the Lagos University Teaching 
Hospital Idi-Araba and the Lagos State University 
Teaching Hospital, Ikeja both located in Lagos 
State, South West of Nigeria and represent the 
largest referral centers in the geographical region. 
A total of 100 subjects participated in this study 
after obtaining verbal consents of participants and 
ethical clearance from the hospital ethical 
committee. The study group comprised forty (40) 
clinically diagnosed cases of stroke for the period 
under study, who presented primarily with blood 
pressure readings above 140/90mm/Hg; hemi-
paresis, and varying degrees of unconsciousness 
and had no other documented history of chronic 
systemic disorders. The remaining 60 participants 
who were clinically stable, age-sex matched and 
apparently healthy individuals were recruited by 
systematic random sampling from out-patient 
department into the control group. 
 
Sample Collection and Processing 
Two venous, non-fasting blood samples of 4.5 
mls each were drawn from individual subjects into 
Na-EDTA and heparin specimen tubes and were 
immediately placed on ice in a cooler. Plasmas 
obtained after centrifugation at 3,000 rpm were 
stored at -20
0
C prior to analysis. Total 
homocysteine assay (tHcy) was determined by 
HPLC using commercial homocysteine 
determination kit (Chromosysteins, Germany) in 
HP Agilent 1100 HPLC systems. Plasma vitamin 
B12 was determined by Chemiluminescent 
Microparticle Immunoassay (CMIA) methods 
using commercial kits (Abbott Laboratory Abott 
park, Chicago, IL) in Architech i 2000 Analyzer. 
Normal ranges in the laboratory are <10μmol/l for 
tHcy and 200-883pmol/l for vitamin B12. 
Haemoglobin concentration (Hb) and mean cell 
volume (MCV) were determined using the 
automated coulter cell counter (Advia TM 60). 
 
Statistical Analysis 
Data obtained were analyzed using the SPSS 
version 11 (SPSS Inc. Chicago). Quantitative 
variables were expressed as mean ± SD; 
differences in mean were subjected to Student t-
test and Fishers exact test where applicable and 
associations verified by Chi-square and Pearson 
correlation coefficient.  
 
RESULT 
Of the total number of stroke patients in the study, 
70% (28 of 40) were males and 30% (12 of 40) 
were females. Mean age of the stroke patients 
was 62±12 years. The mean value of 
homocysteine among the stroke patients was 
17.7±4.4umol/l, and this is significantly higher 
than that of the control at 9.5±2.4umol/l; p<0.001. 
The mean systolic blood pressure and diastolic 
blood pressure for both study group and control 
group as shown in table 1, were 160/102mmHg 
and 125/85mmHg respectively (p=0.000). The 
mean value of plasma vitamin B12 was higher in 
patients with stroke than in the normal subjects 
(249±14.5pmol/l and 203.6±20.5pmol/l 
respectively; p=0.029).  
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Hb (g/dl) 11.6±2.3 12.1±1.6 0.514 
MCV(fl) 85±4.8 82±2.9 0.040 
Homocysteine (umol/L) 17.7±4.4 9.5±2.4 0.000 
Vitamin B12 (pmol/L) 249±14.5 203.6±20.5 0.029 













The mean haemoglobin concentration of the 
stroke patients was 11.6±2.3g/dl. This value was 
lower than the mean haemoglobin concentration 
for the control subjects at 12.1±1.6g/dl, but is not 
statistically significant (p=0.514). However, the 
mean cell volume (MCV) of the stroke patients 
(85 fl) was higher than those of control subjects 
(82 fl) p=0.040. High mean values of plasma 
homocysteine (>10µmol/l) associates well with 
the occurrence of stroke in the respondents, as 
88% of subjects with stroke had elevated 
homocysteine levels above 10µmol/l as shown in 
table 2 (p<0.001;OR 14). Table 3 shows, poor 
association of stroke with plasma vitamin B12 level 
below 200pmol/l (p=0.568; OR 1.08). 
 





 Plasma Homocysteine 
Level (>10µmol/l) 
Plasma 









































Plasma  Vitamin B12 level 
(<200ng/l) 







Study Group 5(45.0) 35(55.0) 40  
 
0.568 
Control Group 7(25.0) 53(75.0) 60 





Of the total number of stroke patients who 
participated in the study, 70% (28 of 40) were 
males and 30% (12 of 40) were females. A 
previous study by Andrew et al. (1999)
 
had shown 
no significant difference in sex prevalence of 
homocysteinaemia. Mean homocysteine level for 
both male and female participants in this study 
were not statistically different (18.2µmol/l and 
17.1µmol/l respectively; p=0.217)]. The mean 
value for plasma homocysteine in the stroke 
patients (17.7±4.4umol/l) was significantly higher 






Sierra Leone J Biomed Res  2009| Vol. 1 No. 2                                               www.sljbr.com 18 
 
These values are similar to that reported by Nura 
et al. (2006)
 
in a study of plasma homocysteine in 
Maiduguri (Northern Nigeria), where they 
recorded mean plasma homocysteine levels of 
20.8umol/l and 13.1umol/l for ischaemic stroke 
and normal control group respectively. The 
association between high levels of plasma 
homocysteine and the incidence of stroke has 
been well documented. Andrew et al. (1999) in a 
study of stroke in some elderly persons concluded 
that total non-fasting plasma homocysteine levels 
are an independent risk factor for the incidence of 
stroke in elderly persons.  
 
In Gombe, Northern Nigeria, Glew et al. (2004) 
showed no significant difference in the plasma 
homocysteine levels of stroke patients and control 
group. In our study however, 85% of the stroke 
patients had plasma homocysteine levels above 
10umol/l, the mean plasma vitamin B12 level 
among the stroke patients (249±14.5pmol/l) 
showed no correlation with rising plasma 
homocysteine levels. This mean value of plasma 
vitamin B12 in the stroke patients is significantly 
higher than plasma vitamin B12 level in the control 
group at 203.6±20.5pmol/l (p=0.029). These 
findings therefore are at variance with other 
studies where lower values of plasma vitamin B12 
were found (Barbe et al., 2009). However, Van 
Guelpan et al. (2005) concluded from a study of 
ischaemic and haemorrhagic stroke that neither 
dietary nor plasma vitamin B12 was associated 
with risk of either subtype of stroke. This seeming 
disparity might be traceable to subtle deficiencies 
in vitamin B12 utilization and disturbances in the 
metabolic pathway as possible aetiological factors 
in some of these patients with 
hyperhomocysteinaemia.  
 
Our study therefore lends support to earlier 
position that vitamin B12 play no significant role in 
the occurrence of stroke. Mean corpuscular 
volume of the stroke patients (85±4.8 fl) was 
significantly higher than those of the control group 
with mean corpuscular volume of 82±2.9fl 
(p=0.040).This when considered with the 
relatively lower haemoglobin concentration 
among the stroke patients (11.6±2.3g/dl vs 
12.1±1.6g/dl), might suggest a possible folate 
deficiency. Haltmayer et al. (2002) in a study 
involving 200 hospitalized patients at the Konvent 
hospital Barmherzige Brueder reported that 
cobalamin (Vitamin B12) and folate deficiencies 
are related to both increased erythrocyte mean 
cellular volume (MCV) and raised serum total 
homocysteine (tHcy) values. The mean values of 
plasma vitamin B12, correlated inversely with the 
plasma homocysteine levels only in the control 
group(r= -0.629, p<0.001).This may imply that in 
health, homocysteine levels rises with decreasing 
levels of vitamin B12. Although, this study made 
attempt to study the controversial relationship 
between vitamin B12 and observed changes in 
plasma homocysteine levels in stroke patients in 
Nigeria; we did not set out to determine plasma 
folate levels. Additionally, almost all previous 
studies were in agreement with the occurrence of 
low plasma folate in patients with stroke. 
Nevertheless, a larger, multi-centre study 
involving larger number of patients might be 
required to further establish these findings among 
stroke patients in Nigeria. 
 
CONCLUSION 
Though this study has been able to indicate an 
inverse relationship between vitamin B12 level and 
homocysteine in healthy individuals, its (vitamin 
B12) role in the aetiology of stroke is largely 
speculative as indicated in similar studies, but 
may in addition to other prevailing factors be a 
potential risk factor for hyperhomocysteinaemia 
and subsequently cardiovascular disorders.  
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